Search results for "Multiple sclerosi"

showing 10 items of 643 documents

Efficacy of 12 weeks of proprioceptive training in patients with multiple sclerosis

2019

This pilot study aims to investigate if specific training protocol can improve the quality of life in people with multiple sclerosis through the improvement of some impaired ability like the balance. We enrolled in our project 20 subjects (age: 34,88 ± 4,45; height: 168,25 ± 8,66 cm; weight: 72,31 ± 17,28 kg) but only 5 completed the study. A proprioceptive training was administered for 12 weeks, 2 times a week, an hour for each session. At the beginning (T0) and at the end of the study (T1), static and dynamic balance parameters were tested. Statistical analyzes were performed using IBM SPSS Statistics 22.Changes in balance and strength between T0, T1 were evaluated using t Student test fo…

medicine.medical_specialtyPaired DataProprioceptionbusiness.industryForefootMultiple sclerosismedicine.diseaseNeurodegenerative diseaseGaitBaropodometryPhysical therapymedicineEducación Física y DeportivaProprioceptive trainingbusinessDynamic balanceProprioceptive training.StatisticBalance (ability)Dynamic balance
researchProduct

A new window in multiple sclerosis pathology: non-conventional quantitative magnetic resonance imaging outcomes

2010

Recent findings suggest that neuronal pathology occurs early in the course of multiple sclerosis and seems to be responsible for accumulation of disability. Nonetheless, the nervous system has an intrinsic potential for repair and compensation in the neuronal component. Disease-modifying drugs such as glatiramer acetate interfere with, and down-regulate, inflammatory pathology and slow neurodegeneration. Moreover, certain regulatory cytokines and neurotrophic factors have the capacity to promote neuronal and axonal repair. Given the importance of neuronal injury in multiple sclerosis and the potential of certain treatments for neuronal repair, it is important to possess adequate and sensiti…

medicine.medical_specialtyPathologyMultiple SclerosisNeuroprotectionNeurotrophic factorsmedicineHumansGlatiramer acetateNeuronsmedicine.diagnostic_testbusiness.industryMultiple sclerosisNeurodegenerationBrainMagnetic resonance imagingAnatomical pathologymedicine.diseaseMagnetic Resonance ImagingAxonsnervous systemNeurologyNeurology (clinical)businessNeuroscienceDiffusion MRImedicine.drugJournal of the Neurological Sciences
researchProduct

Biophysics of venous return from the brain from the perspective of the pathophysiology of chronic cerebrospinal venous insufficiency

2011

This article discusses the biophysical aspects of venous outflow from the brain in healthy individuals and in patients with chronic cerebrospinal venous insufficiency. Blood flows out of the brain differently, depending on body position. In the supine position it flows out mainly through internal jugular veins, while in the upright position it uses the vertebral veins. This phenomenon is probably not due to the active regulation of the flow but instead results from the collapse of jugular veins when the head is elevated. Such a collapse is associated with a significant increase in flow resistance, which leads to redirection of the flow towards the vertebral pathway. Theoretical calculations…

medicine.medical_specialtyPathologySupine positionfluid mechanicsCentral nervous systemmultiple sclerosisBiophysical PhenomenaInternal medicineOcclusionCerebral flowmedicinevenous insufficiencyHumansjugular veinsPharmacologybusiness.industryNervous tissueBrainGeneral Medicinemedicine.diseaseCerebral VeinsPeripheralChronic cerebrospinal venous insufficiencymedicine.anatomical_structureCerebrovascular Circulationcardiovascular systemVascular resistanceCardiologyVascular ResistancebusinessVenous return curveReviews on Recent Clinical Trials
researchProduct

Chronic cerebrospinal venous insufficiency and multiple sclerosis: A commentary

2010

medicine.medical_specialtyPediatricsChronic cerebrospinal venous insufficiencyNeurologybusiness.industryMultiple sclerosisMedicineNeurology (clinical)businessmedicine.diseaseIntensive care medicineAnnals of Neurology
researchProduct

Natalizumab therapy of multiple sclerosis: recommendations of the Multiple Sclerosis Study Group-Italian Neurological Society

2011

Three years after the introduction of natalizumab (NA) therapy for the second line treatment of relapsing-remitting multiple sclerosis (MS), Italian MS centers critically reviewed the scientific literature and their own clinical experience. Natalizumab was shown to be highly efficacious in the treatment of MS. However, the risk of progressive multifocal leukoencephalopathy was confirmed and defined better. This article summarizes the MS-SIN Study Group recommendations on the use of NA in MS, with particular reference to the appropriate selection and monitoring of patients as well as to the management of adverse events.

medicine.medical_specialtyPediatricspml; iris; multiple sclerosis; natalizumabMultiple SclerosisNeurologypmlMEDLINEProgressive MultifocalDermatologyRelapsing-RemittingAntibodies Monoclonal HumanizedAntibodiesLeukoencephalopathyMultiple Sclerosis Relapsing-RemittingNatalizumabLeukoencephalopathyMonoclonalmedicineHumansAdverse effectAntibodies; Monoclonal; Humanized Antibodies; therapeutic use Humans Leukoencephalopathy; Progressive Multifocal; chemically induced Multiple Sclerosis; Relapsing-Remitting; drug therapyHumanizedMultiple sclerosis Natalizumab PML IRISirisbusiness.industryNatalizumabProgressive multifocal leukoencephalopathyMultiple sclerosisLeukoencephalopathy Progressive MultifocalAntibodies MonoclonalGeneral Medicinemedicine.diseasedrug therapyPsychiatry and Mental healththerapeutic usechemically inducednatalizumab multiple sclerosis treatment guidelinesPhysical therapySettore MED/26 - NeurologiaNeurology (clinical)Neurosurgerybusinessmedicine.drug
researchProduct

Multiple sclerosis: Haemorheological pattern

2016

medicine.medical_specialtyPhysiologybusiness.industryPhysiology (medical)Multiple sclerosisImmunologyMedicineHematologyCardiology and Cardiovascular Medicinebusinessmedicine.diseaseDermatologyClinical Hemorheology and Microcirculation
researchProduct

Mortality studies for multiple sclerosis: still a useful tool to analyse long-term outcome

2017

Mortality studies represent a useful way to look at the prognosis of a chronic complex disease and to evaluate the impact of therapeutic and caring strategies on long-term outcomes. Results should be interpreted keeping always in mind the following important aspects: first, to what extent the disease affects patient’s life in terms of life expectancy. Second, what is at this moment the real impact that the strategies and measures we adopt to cure and to take care of patients really have on clear and strong endpoints like mortality? In their JNNP manuscript, Lunde et al .1 show a significant reduction in life expectancy in people affected by multiple sclerosis (MS) over a study period of abo…

medicine.medical_specialtyPopulationComplex diseaseDiseaseOutcome (game theory)03 medical and health sciences0302 clinical medicineNEUROEPIDEMIOLOGYmedicine030212 general & internal medicineIntensive care medicineeducationMULTIPLE SCLEROSISeducation.field_of_studybusiness.industryMultiple sclerosismedicine.diseaseSurgeryTerm (time)Psychiatry and Mental healthLife expectancySettore MED/26 - NeurologiaSurgeryNeurology (clinical)business030217 neurology & neurosurgeryJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

IMPAIRED DECISION-MAKING AND DIFFUSION ORIENTATIONAL COMPLEXITY IN PEOPLE WITH MULTIPLE SCLEROSIS

2013

Objective Difficulties with decision-making have been reported in people with multiple sclerosis (MS). It is however unclear what aspect of decision making is impaired, for example whether they are more impulsive, and how any impairments relate to grey matter pathology. In this study we assess grey matter microstructure using a novel measure of the number of diffusion orientations on diffusion MRI “diffusion orientation complexity (DOC)”. We studied DOC in cortical areas known to be associated with decision making and looked at its associations with performance on the Cambridge Gambling Task (CGT). Method One hundred and five patients with MS (61 RR, 26 SP, 18 PP; mean age: 45.9 years) and …

medicine.medical_specialtySettore M-PSI/02 - Psicobiologia E Psicologia Fisiologicabusiness.industryMultiple sclerosisHippocampusGrey matterAudiologymedicine.diseaseImpulsivityPsychiatry and Mental healthmedicine.anatomical_structuremedicineMiddle frontal gyrusSurgeryNeurology (clinical)HARDI diffusion oriantational complexity multiple sclerosis DTI cognitionmedicine.symptomPrefrontal cortexbusinessAssociation (psychology)NeuroscienceDiffusion MRIJournal of Neurology, Neurosurgery & Psychiatry
researchProduct

Endothelin-1 concentrations in the internal jugular and azygous veins in multiple sclerosis patients: the results of a pilot study

2014

Objectives: In this pilot study we examined the potent vasoconstrictor, endothelin-1, in the blood of multiple sclerosis patients in the context of chronic cerebrospinal venous insufficiency hypothesis. For this purpose we measured endothelin-1 concentrations in blood samples that were obtained during selective catheterisation of the main veins draining the central nervous system: the internal jugular veins and the azygous vein. Material and methods: We measured endothelin-1 concentrations in peripheral blood in nine multiple sclerosis patients and five healthy controls. In multiple sclerosis patients this peptide was also evaluated in blood samples obtained from the internal jugular veins …

medicine.medical_specialtybusiness.industryMultiple sclerosismedicine.medical_treatmentazygous veinCentral nervous systemContext (language use)multiple sclerosismedicine.diseaseEndothelin 1jugular veinPeripheralChronic cerebrospinal venous insufficiencymedicine.anatomical_structureInternal medicineAngioplastyJugular veinendothelin-1cardiovascular systemmedicineCardiologybusinessPhlebological Review
researchProduct

Internal jugular vein entrapment in a multiple sclerosis patient.

2012

We describe a multiple sclerosis patient presenting with compression of the internal jugular vein caused by aberrant omohyoid muscle. Previously this patient underwent balloon angioplasty of the same internal jugular vein. Ten months after this endovascular procedure, Doppler sonography revealed totally collapsed middle part of the treated vein with no outflow detected. Still, the vein widened and the flow was restored when the patient’s mouth opened. Thus, the abnormality was likely to be caused by muscular compression. Surgical exploration confirmed that an atypical omohyoid muscle was squeezing the vein. Consequently, pathological muscle was transected. Sonographic control three weeks af…

medicine.medical_specialtybusiness.industryMultiple sclerosismedicine.medical_treatmentlcsh:SurgeryCase Reportlcsh:RD1-811Omohyoid musclemedicine.diseaseBalloonSurgeryDoppler sonographyEntrapmentmedicine.anatomical_structureAngioplastymedicinecardiovascular systemPharmacology (medical)VeinbusinessInternal jugular veinCase reports in surgery
researchProduct